9.26 USD
↘ 0.11 (1.17%)AT CLOSE (11:59 AM EDT)
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOTNASDAQ • USD
9.20
↘ 0.06 (0.64%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
9.20
↘ 0.06 (0.64%)
Market: CLOSED
Shares of BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) are trading at $9.26. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest BBOT is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 26, 2026.
Open?$9.36
High?$9.47
Low?$9.04
Prev. Close?$9.37
Volume?247.2K
Avg. Volume?268.5K
VWAP?$9.32
Rel. Volume?0.92x
Bid / Ask
Bid?$8.90 × 100
Ask?$9.80 × 100
Spread?$0.90
Midpoint?$9.35
Valuation & Ratios
Market Cap?742.4M
Shares Out?80.2M
Float?24.8M
Float %?31.0%
P/E Ratio?N/A
P/B Ratio?2.30
EPS?-$2.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Employees
88
Market Cap
751.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-08-12
Address
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA 94080
Phone: 857 702 0377
SOUTH SAN FRANCISCO, CA 94080
Phone: 857 702 0377
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?50
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?5.58Safe
Confidence?28%Very Low
Short InterestSqueeze Risk
Short % of Float?23.42%Squeeze Risk
Short Interest?5.8M
Days to Cover?24.8
Free Float24.8M
Avg Daily Volume234.2K
Settlement Date2026-08-14
Financial Health
Current Ratio?4.69Strong
Quick Ratio?4.69Strong
Cash Ratio?1.05Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.30CHEAP▾
Peers100
S&P68
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-56.4%WEAK▾
S&P3
ROA?-48.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-193815454
Enterprise Value?$688.4M
Fundamentals ratios updated end of day